Major ABO Incompatibility in Non‐Myeloablative Hematopoietic Stem Cell Transplant for Sickle Cell Disease—Not an Insurmountable Obstacle
- 9 January 2025
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (4) , e31515
Abstract
With advances in conditioning strategies and graft‐versus‐host disease (GvHD) prevention, hematopoietic stem cell transplantation (HSCT) is a safe, curative treatment option for pediatric patients with sickle cell disease (SCD). However, donor options have been limited in non‐myeloablative matched sibling donor (MSD) setting by excluding recipients with major ABO blood group incompatible donors due to concern of the risk of significant complications such as pure red cell aplasia (PRCA). We present three cases of successful HSCT with major ABO incompatibility with their donors, and discuss strategies to safely expand the donor pool to include these donors.Keywords
This publication has 23 references indexed in Scilit:
- Favorable outcome of non‐myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patientsAmerican Journal of Hematology, 2024
- Nonmyeloablative Matched Sibling Donor Hematopoietic Cell Transplantation in Children and Adolescents with Sickle Cell DiseaseTransplantation and Cellular Therapy, 2019
- Immunomodulatory effects of CD38-targeting antibodiesImmunology Letters, 2018
- Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug TreatmentClinical Pharmacokinetics, 2016
- Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell PhenotypeJAMA, 2014
- Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible DonorsTransplantation and Cellular Therapy, 2013
- Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantationBone Marrow Transplantation, 2011
- Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell DiseaseNew England Journal of Medicine, 2009
- Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemiaTransplantation and Cellular Therapy, 2001
- Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in BelgiumBone Marrow Transplantation, 1998